Xenogeneic Arterial Bypass Graft

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 HL53192-01,
Agency Tracking Number: 29497
Amount: $73,360.00
Phase: Phase I
Program: SBIR
Awards Year: 1995
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
2211 New Market Parkway, Suite, Marietta, GA, 30067
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Steven Goldstein
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract
Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatofeasibility study in canine subjects to determine whether an immunologically modified xenogeneic vesendothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend tothe tissue modification technique, and seek to optimize endothelial cell seeding. The final object oassess in vivo the biocompatibility of the implant, as well as its overall effectiveness as a graft.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government